HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Christopher M Blanchette Selected Research

salmeterol (Serevent)

12/2012Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.
1/2011Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.
1/2010Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patients.
11/2009Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
11/2009Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.
10/2009Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
9/2009Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
1/2009Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD.
1/2009Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.
8/2008Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Christopher M Blanchette Research Topics

Disease

13Chronic Obstructive Pulmonary Disease (COPD)
03/2011 - 06/2007
8Asthma (Bronchial Asthma)
02/2015 - 07/2008
2Autosomal Dominant Polycystic Kidney (ADPKD)
04/2015 - 01/2014
2Chronic Bronchitis
11/2010 - 01/2009
2Hyperkalemia
11/2010 - 04/2010
1Pneumonia (Pneumonitis)
01/2014
1Cachexia
01/2014
1Dyspnea (Shortness of Breath)
03/2011
1Chronic Kidney Failure (Chronic Renal Failure)
03/2011
1Hypertension (High Blood Pressure)
03/2011
1Cardiovascular Diseases (Cardiovascular Disease)
03/2011
1Sepsis (Septicemia)
12/2010
1Infection
12/2010
1Candidemia
12/2010
1Invasive Candidiasis
12/2010
1Lung Neoplasms (Lung Cancer)
11/2010
1Kidney Diseases (Kidney Disease)
04/2010
1Myocardial Infarction
04/2008
1Schizophrenia (Dementia Praecox)
01/2008

Drug/Important Bio-Agent (IBA)

12salmeterol (Serevent)FDA Link
12/2012 - 06/2007
12fluticasone (Cutivate)FDA LinkGeneric
12/2012 - 06/2007
7Ipratropium (Ipratropium Bromide)FDA LinkGeneric
01/2011 - 06/2007
5Albuterol (Salbutamol)FDA LinkGeneric
01/2011 - 07/2008
43- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA
01/2011 - 09/2009
3Adrenal Cortex Hormones (Corticosteroids)IBA
02/2015 - 09/2009
3tiotropium (Spiriva)FDA Link
01/2011 - 01/2009
2salmeterol drug combination fluticasone (Advair)IBA
12/2012 - 07/2008
2fluticasone propionate - salmeterol combinationIBA
01/2011 - 01/2010
2PotassiumIBA
11/2010 - 04/2010
2Budesonide (Pulmicort)FDA LinkGeneric
11/2009 - 09/2009
2formoterol (Oxis)FDA Link
11/2009 - 09/2009
2Leukotriene Receptors (Leukotriene Receptor)IBA
11/2009 - 09/2009
1tolvaptanFDA Link
01/2014
1insulin receptor-related receptor (IRR)IBA
01/2014
1Transcription Factors (Transcription Factor)IBA
08/2012
1DNA (Deoxyribonucleic Acid)IBA
08/2012
1beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
03/2011
1Proton Pump InhibitorsIBA
03/2011
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
03/2011
1Cholinergic Antagonists (Anticholinergics)IBA
01/2011
1GoldIBA
01/2011
1Fluconazole (Zonal)FDA LinkGeneric
12/2010
1SmokeIBA
11/2010
1Bronchodilator Agents (Bronchodilators)IBA
01/2009
1Carbon MonoxideIBA
07/2008
1Serotonin (5 Hydroxytryptamine)IBA
04/2008
1Antipsychotic Agents (Antipsychotics)IBA
01/2008

Therapy/Procedure

2Length of Stay
01/2014 - 01/2008
2Ambulatory Care (Outpatient Care)
01/2011 - 01/2011
1Nephrectomy
04/2015
1Transplants (Transplant)
04/2015
1Long-Term Care
10/2009
1Nebulizers and Vaporizers (Inhaler)
07/2008
1Drug Therapy (Chemotherapy)
06/2007